Pfizer announced promising results for its antiviral COVID-19 treatment, with clinical trials showing the drug nearly 90 percent effective at preventing hospitalizations and deaths from COVID-19.
Pfizer announced promising results for its antiviral COVID-19 treatment, with clinical trials showing the drug nearly 90 percent effective at preventing hospitalizations and deaths from COVID-19.